Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

BACKGROUND: In Papua, Indonesia, maternal malaria is prevalent, multidrug resistant and associated with adverse outcomes for mother and baby. In March 2006, anti-malarial policy was revised for the second and third trimester of pregnancy to dihydroartemisinin–piperaquine (DHP) for all species of mal...

全面介紹

Na minha lista:
書目詳細資料
發表在:Malar J
Main Authors: Poespoprodjo, Jeanne Rini, Fobia, Wendelina, Kenangalem, Enny, Lampah, Daniel A, Sugiarto, Paulus, Tjitra, Emiliana, Anstey, Nicholas M, Price, Richard N
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4501192/
https://ncbi.nlm.nih.gov/pubmed/26169783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0794-0
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍